Latest Period
Q1 2026
Security Snapshot
Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) Institutional Ownership
CUSIP: 984015602
13F Institutional Holders and Ownership History from Q2 2023 to Q1 2026
Institutions Reporting
6
Shares (Excl. Options)
169,120
Price
$2.68
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- XBIO on Nasdaq
- Shares outstanding
- 2,290,667
- Price per share
- $3.38
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 169,120
- Total reported value
- $453,024
- % of total 13F portfolios
- 0%
- Share change
- -66,405
- Value change
- -$162,663
- Number of holders
- 6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 984015602.
- 6 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 6 between Q4 2025 and Q1 2026.
- Reported value moved from $496,638 to $453,024.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 6 institutions filings for Q1 2026.
Security key
984015602
Latest holder period
Q1 2026
13F holders
6
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
XBIO full holder history
Xenetic Biosciences, Inc. SEC filings
Xenetic Biosciences, Inc. company facts
Xenetic Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 984015602:
Significant Owners of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 6% | -22% | $439,808 | -$131,421 | 137,440 | -23% | Renaissance Technologies LLC | 31 Mar 2026 |
As of 31 Mar 2026, 6 institutional investors reported holding 169,120 shares of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO). This represents 7.4% of the company’s total 2,290,667 outstanding shares.
Institutional Holders of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 169,120 | $453,024 | -$162,663 | $2.68 | 6 |
| 2025 Q4 | 228,794 | $496,638 | +$355,037 | $2.17 | 11 |
| 2025 Q3 | 58,138 | $183,741 | -$25,655 | $3.15 | 10 |
| 2025 Q2 | 64,211 | $250,169 | -$109,737 | $3.92 | 9 |
| 2025 Q1 | 107,313 | $292,493 | +$46,588 | $2.61 | 12 |
| 2024 Q4 | 89,449 | $356,056 | +$160,445 | $4.00 | 13 |
| 2024 Q3 | 48,734 | $211,621 | +$146,292 | $4.34 | 9 |
| 2024 Q2 | 14,882 | $62,048 | -$18,275 | $4.07 | 5 |
| 2024 Q1 | 19,610 | $73,775 | +$10,085 | $3.77 | 7 |
| 2023 Q4 | 16,935 | $60,671 | -$1,088 | $3.45 | 7 |
| 2023 Q3 | 17,288 | $79,405 | -$44,568 | $4.90 | 7 |
| 2023 Q2 | 36,642 | $120,375 | +$120,375 | $3.28 | 9 |